Branded vs Generic Medicines”

Meeting Details

Meeting Date 21 Mar 2024
Meeting Time 07:00:00
Location Poona Club
Meeting Type Regular
Meeting Topic Branded vs Generic Medicines”
Meeting Agenda 7-7.30- Fellowship 7.30- Meeting called to order National Anthem Welcome by President Greeting Announcements Guest Speaker
Chief Guest Rtn Vinod Dua, Director Medical RCPD
Club Members Present 38
Minutes of Meeting On March 21st, RCPD's own director( medical), Rtn. Vinod Dua presented a ppt. titled 'BRANDED vs GENERIC MEDICINES', the unsolved dilemma, with a tagline “ a bottle of medicine Or is it a battle of Medicine”. He was introduced specifically regarding his background by Rtn. Pradeep bhai, in his apt HINDI narrative filled with comraderie as they both are and interesting anecdotes and shayari. The speaker himself acknowledged at the beginning his vast 48 years of experience in the said subject of Medicine and Pharma companies in India and abroad. The slides show started with definitions for every layman to understand and get in the groove of the topic. Common medicines used by men and women after a certain age were highlighted pointing out familiar Brand names. Immediate to naming them were mentioned their actual formulations which are their compound Generic product names Important points covered during the presentation were Patents, Indian and US FDA, and Molecules, which may be Stable or Unstable. Generics in India made the next level of discussion with their classification as in the market today. There was a comparison chart given as well as a Table distinguishing between the Prescription Branded Generics and Trade Branded Generics and OTCs ( over the counter) Medicines with applied parameters like Reputable companies, doctors and the Pros and Cons and the speakers personal advice included. The role of Insurance and the Doctors were emphasized in every slide in the lucid presentation. Rtn. Vinod then came in the front for an interactive continuation of the discussion so that he could talk about the general perception of the people and society and concerns with patients in India including attributes like Quality and Potency of the drugs available. Last highlight was how the battle will continue in India until it achieves its goal of becoming a developed nation.